SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Gold/Mining/Energy : Nuvo Research Inc

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Jeff Chan who wrote (4247)8/2/2000 2:22:59 PM
From: Cal Gary  Read Replies (2) of 14101
 
Jeff, or actually anyone else here

For example, when tech companies go on a road show to the brokers, they normally bring a notebook computer (or device) to showcase their wares. The brokers get a look and "feel" for the technology. I am wondering how this is done in the pharma sector. So the dumb question of the day is:

"When approved, on a institutional roadshow, can DMX bring samples of Pennsaid (yes I know prescription only) to let brokers/analyst/managers look and FEEL the product? How about before approval is attained?? Or does a doctor need to be present."

Wolf, the pharmacy (or rather should I say the pharmacist) is NOT the primary driver for prescription sales. This
belongs to the physician. That's why almost all marketing efforts go towards trying to persuade the physician to use
the product. This occurs through one to one visits (otherwise known as detailing), medical education events by
"specialists or recognized authorities" in a specific area of treatment, and through the distribution of samples at the
doctor's offices.


Sell to doctors to get product sales going.
Sell to broker/analyst/fund managers to get shares going.

Thanks.

PS Exciting volume, 180K, even better at 1 million a day.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext